- Report
- September 2023
- 87 Pages
Africa, Middle East
From €2582EUR$2,950USD£2,244GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3019EUR$3,450USD£2,625GBP
- Report
- September 2023
- 101 Pages
North America
From €2582EUR$2,950USD£2,244GBP
- Report
- September 2023
- 194 Pages
Global
From €4332EUR$4,950USD£3,766GBP
- Report
- October 2022
- 194 Pages
Global
From €4376EUR$5,000USD£3,804GBP
- Report
- February 2021
- 80 Pages
India
From €1041EUR$1,190USD£905GBP
- Report
- January 2021
- 109 Pages
Global
€3990EUR$4,884USD£3,590GBP
- Report
- September 2025
- 85 Pages
Global
From €3500EUR$4,284USD£3,149GBP
- Report
- August 2025
- 105 Pages
Global
From €3500EUR$4,284USD£3,149GBP
- Report
- November 2024
- 78 Pages
Global
From €3500EUR$4,284USD£3,149GBP
- Report
- November 2024
- 86 Pages
Global
From €3500EUR$4,284USD£3,149GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more